Cantitate/Preț
Produs
Total produse
Vezi coșul
New Horizons in Predictive Toxicology: Current Status and Application de Alan G. E. Wilson

New Horizons in Predictive Toxicology: Current Status and Application: RSC Drug Discovery, cartea 12

Editat de Alan G. E. Wilson, David E. Thurston, David Rotella
en Limba Engleză Hardback – 31 oct 2011
Modelling and simulation technologies have improved dramatically over the past decade and their applications in toxicity prediction and risk assessment are of great importance. Such approaches will become increasingly necessary as industrial chemicals advance and as new pharmaceuticals enter the market. In this comprehensive discussion of predictive toxicology and its applications, leading experts express their views on the technologies currently available and the potential for future developments. The book covers a wide range of topics including the in silico, in vitro and in vivo approaches being used in the safety assessment of chemical substances. It reflects the growing and urgent need to strengthen our ability to predict the risks posed by industrial and pharmaceutical chemicals in humans. Extensive information on the use of current animal models used for various toxicities and target-mediated toxicities is included. Also discussed are the recently introduced regulatory initiatives.
Citește tot Restrânge

Din seria RSC Drug Discovery

  • 27% Synthetic Methods in Drug Discovery: Complete Set
    Preț: 220406 lei
  • 14% Drug Transporters: Recent Advances and Emerging Technologies
    Preț: 116551 lei
  • 5% New Horizons in Predictive Drug Metabolism and Pharmacokinetics
    Preț: 142236 lei
  • 5% Neglected Diseases and Drug Discovery
    Preț: 108876 lei
  • 5% Polyamine Drug Discovery
    Preț: 108006 lei
  • 14% Proteinases as Drug Targets: Rsc
    Preț: 97729 lei
  • 5% Kinase Drug Discovery
    Preț: 108183 lei
  • 14% Drug Design Strategies
    Preț: 102662 lei
  • 14% Designing Multi-Target Drugs
    Preț: 113518 lei
  • 14% Nanostructured Biomaterials for Overcoming Biological Barriers: Rsc
    Preț: 108067 lei
  • 5% Drug Discovery from Natural Products: Rsc
    Preț: 130394 lei
  • 14% Drug Discovery for Psychiatric Disorders: Rsc
    Preț: 118454 lei
  • 9% Organic Chemistry of Drug Degradation
    Preț: 106706 lei
  • 14% Computational Approaches to Nuclear Receptors
    Preț: 98858 lei
  • 14% Traditional Chinese Medicine: Scientific Basis for Its Use
    Preț: 110524 lei
  • 14% Successful Strategies for the Discovery of Antiviral Drugs: Rsc
    Preț: 118481 lei
  • 5% Inhibitors of Molecular Chaperones as Therapeutic Agents
    Preț: 147680 lei
  • 14% Macrocycles in Drug Discovery
    Preț: 129078 lei
  • 5% Cardiovascular and Metabolic Disease
    Preț: 145287 lei
  • 14% Green Chemistry Strategies for Drug Discovery
    Preț: 131208 lei
  • 5% Fragment-Based Drug Discovery
    Preț: 136847 lei
  • 5% New Frontiers in Chemical Biology: Enabling Drug Discovery
    Preț: 108130 lei
  • 5% Privileged Scaffolds in Medicinal Chemistry
    Preț: 145806 lei
  • 14% Nanomedicines
    Preț: 131364 lei
  • 14% Drug Transporters: Role and Importance in Adme and Drug Development
    Preț: 131993 lei
  • 14% G Protein-Coupled Receptors
    Preț: 125493 lei
  • 14% Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of the Building Blocks of Medicinal Chemistry on ADMET
    Preț: 107725 lei
  • 5% Emerging Drugs and Targets for Alzheimer's Disease, Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism
    Preț: 117781 lei
  • 5% Emerging Drugs and Targets for Alzheimer's Disease, Volume 2: Neuronal Plasticity, Neuronal Protection and Other Miscellaneous Strategies
    Preț: 117712 lei
  • 14% Neurodegeneration: Metallostasis and Proteostasis
    Preț: 89998 lei
  • 14% New Synthetic Technologies in Medicinal Chemistry: Rsc
    Preț: 73855 lei
  • 14% Drug Design Strategies: Quantitative Approaches
    Preț: 107930 lei
  • 14% Pain Therapeutics: Current and Future Treatment Paradigms
    Preț: 117898 lei
  • 5% Orphan Drugs and Rare Diseases: Rsc
    Preț: 142413 lei
  • 9% Accounts in Drug Discovery: Case Studies in Medicinal Chemistry
    Preț: 92361 lei
  • 5% Pharmaceutical Process Development: Current Chemical and Engineering Challenges
    Preț: 88660 lei
  • 5% Extracellular and Intracellular Signaling: Rsc
    Preț: 96467 lei
  • 5% Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents
    Preț: 105239 lei
  • 9% Pharmaceutical Salts and Co-Crystals
    Preț: 100630 lei
  • 9% Physico-Chemical and Computational Approaches to Drug Discovery
    Preț: 106832 lei
  • 9% Biomarkers for Traumatic Brain Injury: Rsc
    Preț: 76405 lei
  • 9% Anti-Inflammatory Drug Discovery
    Preț: 111077 lei
  • 5% New Therapeutic Strategies for Type 2 Diabetes: Small Molecule Approaches
    Preț: 116016 lei
  • 5% Comprehensive Biomarker Discovery and Validation for Clinical Application: Rsc
    Preț: 115756 lei
  • 5% Emerging Drugs and Targets for Parkinson's Disease
    Preț: 115806 lei
  • 5% Biotherapeutics
    Preț: 115711 lei
  • 9% Ion Channel Drug Discovery
    Preț: 121171 lei
  • 5% Human-Based Systems for Translational Research
    Preț: 112012 lei

Preț: 147041 lei

Preț vechi: 154779 lei
-5% Nou

Puncte Express: 2206
Preț estimativ în valută:
28145€ • 30265$ • 23457£

Carte disponibilă

Livrare economică 29 noiembrie-13 decembrie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781849730518
ISBN-10: 1849730512
Pagini: 732
Ilustrații: There are some colour figures for this book. This has been approved by the Comm
Dimensiuni: 162 x 241 x 44 mm
Greutate: 1.18 kg
Editura: Royal Society Of Chemistry
Seria RSC Drug Discovery

Cuprins

Introduction and overview; computational modeling approaches: in silico tools for toxicity prediction, development of an evaluation support system for estimating repeated dose toxicity of chemicals based on chemical structure, towards a common regulatory framework for computational toxicology: current status and future perspectives, information, informatics and modeling in predictive toxicology; in vitro approaches in predicting toxicity: cellular stress and in vitro predictive toxicology, in vitro genotoxicity, cardiac toxicity prediction: to simplify, or to integrate, that is the question, in vitro approaches for determining liver specific toxicity of new drug candidates, human-based in vitro experimental systems for the assessment of human-specific adverse drug effects: scientific concepts, current applications and promising approaches, models of organ injury,mitochondrial toxicity; in vivo approaches in predicting toxicity: nonclinical models for the evaluation of mechanisms of toxicity,in vivo genetic toxicology: application to cancer risk assessment, predicting hepatic toxicity in vivo, immunotoxicity testing,reproductive toxicity,toxicity biomarkers,renal toxicity, integrative approaches to toxicity prediction, metabolism-based toxicity prediction,impact of drug transporters in the pharmacological and adverse reactions of drugs,toxicokinetics, the role of computational systems biology models in toxicity testing in the 21st century: an example with predictive multi-scale models of the liver, animal models of idiosyncratic, drug-induced liver injury

Notă biografică

Alan G. E. Wilson, PhD, ATS, is currently Vice President of Drug Metabolism, Pharmacokinetics, and Toxicology and Pathology at Lexicon Pharmaceuticals. He is internationally-recognized in drug metabolism, pharmacokinetics and toxicology and has over 25 years of experience working on product discovery and development for both small molecules and biotherapeutics. He has significant hands-on experience with the regulatory and GLP requirements for the conduct of ADME, PK and safety assessment studies to support regulatory submissions and clinical studies. Prior to joining Lexicon, Dr. Wilson held senior management and leadership positions with major international pharmaceutical and life science companies. He has been involved with the approval and registration of several successful marketed products and has extensive experience working with regulatory agencies in the United States, Europe and Asia Pacific. Dr. Wilson has Board of Director and Scientific Advisory experience with several companies. He is Board Certified in Toxicology and has produced more than 120 publications. Dr. Wilson has been an invited speaker and presenter at international conferences.

Textul de pe ultima copertă

The sophistication of modelling and simulation technologies have improved dramatically over the past decade and their applications in toxicity prediction and risk assessment are of critical importance. The integration of predictive toxicology approaches will become increasingly necessary as industrial chemicals advance and as new pharmaceuticals enter the market. In this comprehensive discussion of predictive toxicology and its applications, leading experts express their views on the technologies currently available and the potential for future developments. The book covers a wide range of topics including in silico, in vitro and in vivo approaches that are being used in the safety assessment of chemical substances. It reflects the growing and urgent need to strengthen and improve our ability to predict the safety and risks posed by industrial and pharmaceutical chemicals in humans. The reader will find extensive information on the use of current animal models used for various toxicities and target mediated toxicities. Also discussed are the recent regulatory initiatives to improve the safety assessment of chemicals. The book provides an expert and comprehensive discussion on the current status and future directions of predictive toxicology and its application. The various chapters in the book also reflect the growing need for improvements in our technologies and abilities to predict toxicities of pharmaceutical and industrial chemicals to ensure product safety and protect public health.

Descriere

Modelling and simulation technologies have improved dramatically over the past decade and their applications in toxicity prediction and risk assessment are of great importance. In this comprehensive discussion of predictive toxicology and its applications, leading experts express their views on the technologies currently available and the potential for future developments.